现金管理

Search documents
证券代码:603307 证券简称:扬州金泉 公告编号:2025-026
Zhong Guo Zheng Quan Bao - Zhong Zheng Wang· 2025-06-04 23:15
● 履行的审议程序:扬州金泉旅游用品股份有限公司(以下简称"公司")于2025年2月25日召开第二届 董事会第二十次会议、第二届监事会第十八次会议,分别审议通过了《关于使用部分暂时闲置募集资金 进行现金管理的议案》。 ● 特别风险提示:公司本次现金管理产品为保证本金的低风险产品,但产品可能面临多重风险因素,包 括但不限于政策风险、市场风险、延迟兑付风险、流动性风险、再投资风险、募集失败风险、信息传递 风险、不可抗力及意外事件风险等。敬请广大投资者谨慎决策,注意防范投资风险。 一、现金管理产品到期赎回情况 登录新浪财经APP 搜索【信披】查看更多考评等级 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏,并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容提示: ● 本次现金管理产品种类:结构性存款 ● 本次现金管理额度:人民币5,500万元 2025年3月3日,公司购买招商银行结构性存款6,000万元,具体内容详见公司披露的《关于使用部分暂 时闲置募集资金进行现金管理的进展公告》(公告编号:2025-012)。 公司于近日对上述产品进行了赎回,收回本金人民币6,000万元 ...
明德生物: 关于开立募集资金现金管理产品专用结算账户的公告
Zheng Quan Zhi Xing· 2025-06-04 12:24
Core Viewpoint - The company has approved the use of idle raised funds for cash management, allowing investment in low-risk financial products up to 230 million yuan, aiming to enhance fund utilization efficiency and increase returns for the company and its shareholders [1][4]. Group 1: Investment Management - The company will use no more than 230 million yuan of idle raised funds for investments in safe, liquid, and principal-protected financial products or time deposits, with the funds being available for rolling use within 12 months from the shareholder meeting approval [1]. - A dedicated settlement account for the raised funds has been established, ensuring that these funds will only be used for cash management and will not be mixed with non-raised funds [3]. Group 2: Risk Control Measures - The company will adhere to prudent investment principles, selecting reputable financial institutions with strong risk control measures for cash management [2]. - The company will conduct timely analysis and monitoring of the financial products' performance, taking necessary actions if risks to fund safety are identified [2]. - The audit department will oversee the use and custody of funds related to this cash management initiative, ensuring compliance and risk evaluation [2]. Group 3: Impact on Operations - The establishment of the dedicated settlement account and the planned cash management will not alter the intended use of raised funds, ensuring that daily operations and investment projects remain unaffected [2]. - The company emphasizes that this strategy is aimed at safeguarding the required funds for investment projects while enhancing the overall safety and efficiency of fund usage [2].
正川股份: 申万宏源证券承销保荐有限责任公司关于重庆正川医药包装材料股份有限公司使用部分闲置募集资金进行现金管理的核查意见
Zheng Quan Zhi Xing· 2025-06-04 12:13
申万宏源证券承销保荐有限责任公司 关于重庆正川医药包装材料股份有限公司 使用部分闲置募集资金进行现金管理的核查意见 申万宏源证券承销保荐有限责任公司(以下简称"保荐人")作为重庆正川 医药包装材料股份有限公司(以下简称"公司"或"正川股份")公开发行可转 换公司债券的保荐人,根据《证券发行上市保荐业务管理办法》《上市公司监管 指引第2号——上市公司募集资金管理和使用的监管要求》《上海证券交易所上 市公司自律监管指引第1号—规范运作》以及《上海证券交易所上市公司自律监 管指引第11号—持续督导》等有关规定等有关规定对正川股份使用部分闲置募集 资金进行现金管理的事项进行了核查,具体如下: 一、公司公开发行可转换公司债券募集资金基本情况 经中国证券监督管理委员会《关于核准重庆正川医药包装材料股份有限公司 公开发行可转换公司债券的批复》(证监许可2021198 号)核准,公司于 2021 年 4 月 28 日公开发行可转换公司债券 405 万张,每张面值 100 元人民币。本次 发 行 可 转 换 公 司 债 券 募 集 资 金 总 额 405,000,000 元 , 扣 除 发 行 费 人 民 币 募集资金已于 2 ...
正川股份: 第四届监事会第十五次会议决议公告
Zheng Quan Zhi Xing· 2025-06-04 12:04
证券代码:603976 证券简称:正川股份 公告编号:2025-029 债券代码:113624 债券简称:正川转债 重庆正川医药包装材料股份有限公司 表决结果:3 票同意、0 票反对、0 票弃权。 具体内容详见公司同日在指定信息披露媒体上披露的《关于使用部分闲置募 集资金进行现金管理的公告》(公告编号:2025-030)。 在不影响公司日常经营活动所需资金并确保资金安全的前提下,公司对闲置 自有资金进行现金管理,有利于提高资金使用效率,增加公司收益,符合公司及 全体股东的利益,不存在损害公司及中小股东利益的情形。因此,监事会同意公 司使用单日最高余额不超过人民币 30,000 万元(含 30,000 万元)的闲置自有资 金进行现金管理,购买安全性高、流动性好、中低风险的投资产品,包括但不限 于银行理财产品、券商理财产品、信托理财产品、结构性存款、通知存款、大额 存单等,单笔投资产品期限不超过 3 年。 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 一、监事会会议召开情况 重庆正川医药包装材料股份有限公司(以下简称"公司")于 ...
长江通信: 长江通信关于使用部分闲置募集资金进行现金管理赎回的公告
Zheng Quan Zhi Xing· 2025-06-04 10:23
Core Viewpoint - The company has approved the use of idle raised funds for cash management, ensuring that it does not affect the implementation of investment plans and effectively controls investment risks [1][2]. Summary by Sections Cash Management Plan - The company will use up to RMB 586 million of temporarily idle raised funds for cash management, investing in low-risk, high-liquidity financial products with principal protection from reputable financial institutions [1]. - The investment period will not exceed 12 months from the date of board approval, allowing for rolling use of funds within the specified limit [1]. Redemption Situation - The company redeemed RMB 5 million of temporarily idle raised funds through a 7-day notice deposit with China Merchants Bank, receiving a total return of RMB 7,777.78 [1]. - The principal and earnings from this investment have been returned to the raised funds account [1]. Recent Cash Management Activities - In the past 12 months, the company has made 6 investments in cash management products totaling RMB 716 million, with 2 redemptions amounting to RMB 135 million and 4 investments still outstanding totaling RMB 581 million [1]. - The highest single-day investment amount in the last 12 months was RMB 586 million, representing 16.58% of the company's net assets for the past year [1]. Financial Performance Metrics - The cumulative return from cash management in the last 12 months is 0.0056% of the company's net profit for the same period [2]. - The total amount of funds currently utilized for financial management is RMB 581 million, with an unused limit of RMB 5 million, making the total financial management limit RMB 586 million [2].
科安达: 关于使用部分闲置募集资金和闲置自有资金进行现金管理的进展公告
Zheng Quan Zhi Xing· 2025-06-04 10:23
Core Viewpoint - Shenzhen Kanda Electronics Technology Co., Ltd. has approved the use of idle raised funds and self-owned funds for cash management, ensuring that it does not affect normal operations and the construction of investment projects [2]. Group 1: Cash Management Approval - The company held its sixth board meeting on December 9, 2024, where it approved the proposal to use idle funds for cash management, with a maximum usage period of 12 months [2]. - The board authorized the chairman or authorized personnel to sign relevant contracts within the approved limits [2]. Group 2: Cash Management Details - The company has engaged in cash management using idle raised funds and self-owned funds, with specific details outlined in the announcement [2]. - The total amount of funds involved in cash management is 32,600 million yuan, with various financial products subscribed [4][5]. Group 3: Financial Products and Returns - The company has subscribed to several structured deposit products with different banks, including: - China Merchants Bank's structured deposits with expected annual returns ranging from 1.3% to 2.05% [3][4]. - Bank of China structured deposits with expected returns of 0.64% to 0.85% [6][7]. - The expected returns on these products are designed to enhance the efficiency of fund usage while ensuring capital safety [8].
股市必读:华鹏飞(300350)5月30日主力资金净流出1869.05万元
Sou Hu Cai Jing· 2025-06-02 18:37
Core Viewpoint - On May 30, 2025, Huapengfei (300350) reported a closing price of 6.06 yuan, down 2.73%, with a turnover rate of 7.84% and a trading volume of 369,600 shares, amounting to a transaction value of 227 million yuan [1][2]. Trading Information Summary - On May 30, 2025, the capital flow for Huapengfei indicated a net outflow of 18.69 million yuan from institutional investors, a net outflow of 3.55 million yuan from retail investors, while individual investors saw a net inflow of 22.24 million yuan [2][3]. Company Announcement Summary - The 24th meeting of the fifth board of directors of Huapengfei was held on May 30, 2025, where three proposals were approved, including cash management, foreign exchange derivatives trading, and the 2025 director remuneration plan. A temporary shareholders' meeting is scheduled for June 16, 2025, to review related proposals [2][3][4]. Cash Management Proposal - The company plans to use up to 400 million yuan of idle self-owned funds for cash management, investing in low-risk, high-liquidity products with a maximum term of 12 months. This proposal requires approval from the shareholders' meeting [3][6]. Foreign Exchange Derivatives Trading Proposal - The company intends to use up to 300 million yuan or equivalent foreign currency for foreign exchange derivatives trading aimed at hedging purposes. This proposal also requires approval from the shareholders' meeting and is designed to mitigate foreign exchange risks [3][5][6]. Director Remuneration Plan - The remuneration plan for non-independent directors will consist of a basic annual salary and performance-based salary, with independent directors receiving a pre-tax allowance of 84,000 yuan per year. This proposal will be submitted directly to the shareholders' meeting for approval [3][4].
南网科技: 南网科技:关于第二届监事会第十三次会议决议的公告
Zheng Quan Zhi Xing· 2025-05-30 11:09
Meeting Overview - The second meeting of the Supervisory Board of Southern Power Grid Electric Technology Co., Ltd. was held on May 30, 2025, via in-person and video conference [1] - All five supervisors attended the meeting, which was chaired by Mr. Chen Zhixin [1] - The meeting complied with relevant laws and regulations, ensuring the legality and validity of the resolutions [1] Resolution Summary - The Supervisory Board approved the proposal to increase the use of temporarily idle raised funds for cash management [1] - The board believes that using these funds to purchase high-security, liquid, and capital-preserving products aligns with regulatory requirements and does not affect the normal implementation of investment projects [1] - The maximum amount for cash management was increased from RMB 300 million to RMB 580 million [1]
山东出版: 山东出版关于使用闲置募集资金进行现金管理到期赎回并继续进行现金管理的公告
Zheng Quan Zhi Xing· 2025-05-30 10:48
Core Viewpoint - The company has approved the use of idle raised funds for cash management, specifically investing up to RMB 650 million in low-risk, high-security structured deposit products to enhance fund efficiency and returns for shareholders [1][2][3]. Group 1: Cash Management Product Redemption - The company purchased a structured deposit product from Industrial and Commercial Bank of China (ICBC) on May 30, 2024, with a total investment of RMB 650 million, which matured on May 19, 2025, yielding a total return of RMB 15,697,232.88 [2][3]. - The investment was fully recovered without any overdue amounts, and the funds were returned to the designated account for raised funds [2][3]. Group 2: Fundraising and Investment Purpose - The company raised a total of RMB 2,711.70 million through an initial public offering, with a net amount of RMB 2,620.05 million after deducting issuance costs [3]. - The purpose of using idle funds for cash management is to improve fund efficiency and increase returns without affecting the construction of investment projects [3][4]. Group 3: Investment Details - The total amount allocated for cash management is RMB 650 million, which is the maximum limit set for such investments [4]. - The structured deposit product has a maturity date of May 19, 2026, and is designed to be low-risk with a guaranteed principal [4][5]. Group 4: Risk Management - The structured deposit products are classified as low-risk investments with high security and liquidity, and the company has implemented measures to monitor and manage potential risks [5]. - The management team is responsible for overseeing the cash management products, with the finance department analyzing and tracking the investment's performance [5]. Group 5: Impact on the Company - The cash management initiative is expected to enhance fund efficiency and provide better returns to shareholders without significantly impacting the company's main business or financial status [6]. - The cash management investment represents 10.75% of the company's cash at the end of the most recent reporting period [6].
美康生物: 中天国富证券有限公司关于美康生物科技股份有限公司使用部分闲置募集资金进行现金管理的核查意见
Zheng Quan Zhi Xing· 2025-05-30 10:48
Summary of Key Points Core Viewpoint - The company plans to utilize part of its idle raised funds for cash management to enhance fund efficiency while ensuring that the investment projects' funding needs are met [1][4][7]. Group 1: Fundraising Overview - The company raised a total of RMB 599,999,925.00 by issuing 39,999,995 shares at RMB 15 per share, with a net amount of RMB 586,603,698.59 after deducting issuance costs [1]. - The funds are stored in a special account designated for this issuance, managed under a regulatory agreement with banks and the sponsor [2]. Group 2: Fund Utilization and Idle Reasons - As of May 29, 2025, the company has utilized RMB 58,660.37 million of the total RMB 62,233.01 million allocated for the in vitro diagnostic product R&D and industrialization project [2]. - The company anticipates temporary idleness of funds due to the phased nature of project construction, leading to a plan for cash management of idle funds [2][4]. Group 3: Previous Cash Management - The company previously approved the use of up to RMB 10,000 million of idle funds for cash management, with the authorization expiring on March 14, 2025 [3][4]. - The company has not engaged in further cash management activities since the expiration of the previous authorization [4]. Group 4: Current Cash Management Plan - The company intends to continue using up to RMB 10,000 million of idle funds for cash management, with the new authorization valid for 12 months from board approval [4][5]. - The investment will focus on low-risk financial products, ensuring no funds are used for high-risk securities or derivatives [5][6]. Group 5: Decision-Making Process - The board and supervisory committee have approved the cash management plan, ensuring it aligns with regulatory requirements and does not harm shareholder interests [6][7]. - The company will maintain strict oversight and risk control measures during the investment process [6][7].